Уноси

Пројекат-Повезаност полиморфизама гена значајних за метаболизам масти и угљених хидрата са липидним параметрима код пацијената са акутним инфарктом миокарда (2024-01)

S. Vidović, R. Škrbić, V. Vidovic, I. Milovac, N. Maksimović, Ž. Radić Savić, N. Malešević, J. Bećarević, Пројекат-Повезаност полиморфизама гена значајних за метаболизам масти и угљених хидрата са липидним параметрима код пацијената са акутним инфарктом миокарда, МИНИСТАРСТВО ЗА НАУЧНОТЕХНОЛОШКИ РАЗВОЈ И ВИСОКО ОБРАЗОВАЊЕ РЕПУБЛИКЕ СРПСКЕ, Jan, 2024
Dijagnostičko - terapijski vodić za porodičnu medicinu: Srčana insuficijencija (2007)

D. Vulić, D. Kuprešak, M. Krneta, R. Škrbić, G. Tešanović, N. Putnik, V. Petrović, B. Goronja, Dijagnostičko - terapijski vodić za porodičnu medicinu: Srčana insuficijencija, pp. 1 - 12, Udruženje doktora porodične medicine Republike Srpske, Udruženje kardiologa Republike Srpske, Banja Luka, 2007
Effects of Semaglutide Treatment on Psoriatic Lesions in Obese Patients with Type 2 Diabetes Mellitus: An Open-Label, Randomized Clinical Trial (2025-01)

Jelena Petković-Dabić, Ivana Binić, Bojana Carić, Ljiljana Božić, Sanja Umičević-Šipka, Nataša Bednarčuk, Saša Dabić, Mirna Šitum, Snježana Popović-Pejičić, Miloš P. Stojiljković, Ranko Škrbić, Effects of Semaglutide Treatment on Psoriatic Lesions in Obese Patients with Type 2 Diabetes Mellitus: An Open-Label, Randomized Clinical Trial, Biomolecules, Jan, 2025
SIGNIFICANCE OF CYP2C9 IN PRESCRIBING SIPONIMOD THERAPY IN PATIENTS WITH MULTIPLE SCLEROSIS (2024-05)

J. Bećarević, V. Vidović, I. Milovac, R. Škrbić, S. Vidović, SIGNIFICANCE OF CYP2C9 IN PRESCRIBING SIPONIMOD THERAPY IN PATIENTS WITH MULTIPLE SCLEROSIS, Journal of Bioanthropology, May, 2024
Glutathione Transferase P1 Polymorphism rs1138272 Might be a Risk Determinant in Myocardial Infarction (2024-10)

Ž. Radić Savić, V. Vidović, S. Vidović, J. Bećarević, M. Popović Šarić, R. Škrbić, Glutathione Transferase P1 Polymorphism rs1138272 Might be a Risk Determinant in Myocardial Infarction, European Pharmaceutical Journal, Oct, 2024
Assessment of ADRB2 Genetic Polymorphisms with Risk for Myocardial Infarction in Patients from the Republic of Srpska (2024-10)

V. Vidović, J. Bećarević, N. Malešević, N. Maksimović, Ž. Radić Savić, I. Milovac, T. Kovačević Preradović, M. Popović Šarić, S. Vidović, R. Škrbić, Assessment of ADRB2 Genetic Polymorphisms with Risk for Myocardial Infarction in Patients from the Republic of Srpska, European Pharmaceutical Journal, Oct, 2024
Peripheral GABAA receptors - physiological relevance and therapeutic implications (2024-11)

M. Gajić Bojić, J. Aranđelović, R. Škrbić, M. Savić, Peripheral GABAA receptors - physiological relevance and therapeutic implications, PHARMACOLOGY & THERAPEUTICS, Nov, 2024
Modulation of Orosomucoid-like Protein 3 Activity in the Management of Inflammatory Bowel Disease (2024-10)

U. Maličević, V. Rai, R. Škrbić, D. K. Agrawal, Modulation of Orosomucoid-like Protein 3 Activity in the Management of Inflammatory Bowel Disease, Journal of Biotechnology and Biomedicine, Vol. 7, No. 4, pp. 433 - 444, Oct, 2024
Characteristics and Outcomes of Critically Ill Pregnant/Postpartum Women with COVID-19 Pneumonia in Western Balkans, The Republic of Srpska Report (2022)

P. Kovačević, S. Topolovac, S. Dragić, M. Jandrić, D. Momčičević, B. Zlojutro, T. Kovačević, D. Lončar-Stojiljković, V. Đajić, R. Škrbić, V. Ećim-Zlojutro, Characteristics and Outcomes of Critically Ill Pregnant/Postpartum Women with COVID-19 Pneumonia in Western Balkans, The Republic of Srpska Report, Medicina, 2022
Do dynamic changes in haematological and biochemical parameters predict mortality in critically ill COVID-19 patients? (2024)

M. Jandrić, B. Zlojutro, D. Momčičević, S. Dragić, T. Kovačević, V. Đajić, M. Stojiljković, D. Lončar-Stojiljković, R. Škrbić, D. Đurić, P. Kovačević, Do dynamic changes in haematological and biochemical parameters predict mortality in critically ill COVID-19 patients?, Technology and Health Care, 2024
Dynamic changes in coagulation, hematological and biochemical parameters as predictors of mortality in critically ill COVID–19 patients: A prospective observational study. (2023-02)

B. Zlojutro, M. Jandrić, D. Momčičević, S. Dragić, T. Kovačević, V. Đajić, M. Stojiljković, R. Škrbić, D. Đurić, P. Kovačević, Dynamic changes in coagulation, hematological and biochemical parameters as predictors of mortality in critically ill COVID–19 patients: A prospective observational study., CLINICAL HEMORHEOLOGY AND MICROCIRCULATION, Vol. 83, No. 2, pp. 137 - 148, Feb, 2023
Comparative Efficacy of High-Dose Dexamethasone Versus Methylprednisolone in Coronavirus Disease 2019 (COVID-19)-Associated Acute Respiratory Distress Syndrome (2024-03)

P. Kovačević, J. Malić, T. Kovačević, S. Dragić, B. Zlojutro, M. Jandrić, D. Momčičević, B. Đajić-Čančarević, R. Škrbić, M. Rizwan, Comparative Efficacy of High-Dose Dexamethasone Versus Methylprednisolone in Coronavirus Disease 2019 (COVID-19)-Associated Acute Respiratory Distress Syndrome, The Cureus Journal of Medical Science: Peer-Reviewed, Open Access, Vol. 16, No. 3, Mar, 2024
Medication Discrepancies in Patients After Transition of Care from Intensive Care Unit to Ward and At Hospital Discharge: A Pilot Study (2024-06)

V. Barišić, T. Kovačević, P. Kovačević, S. Dragić, D. Milaković, D. Momčičević, B. Zlojutro, R. Škrbić, Medication Discrepancies in Patients After Transition of Care from Intensive Care Unit to Ward and At Hospital Discharge: A Pilot Study, LATIN AMERICAN JOURNAL OF PHARMACY, Vol. 43, No. 5, pp. 88 - 96, Jun, 2024
Cardioprotective effects of liraglutide pretreatment on isoprenaline-induced myocardial injury in rats (2023)

Zorislava Bajic, Tanja Sobot, Snezana Uletilovic, Nebojsa Mandic-Kovacevic, Tanja Cvjetkovic, Ugljesa Malicevic, Djordje Djukanovic, Mladen Duran, Nikolina Vesic, Sanja Avram, Sanja Jovicic, Maja Katana, Amela Matavulj, Nenad Ponorac, Dragan M Djuric, Milos Stojiljkovic, Ranko Skrbic, Cardioprotective effects of liraglutide pretreatment on isoprenaline-induced myocardial injury in rats, CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, Vol. 00, pp. 1 - 10, 2023
Klinička farmakologija u gerijatriji (2018)

L. Nežić, R. Škrbić, S. Stoisavljević-Šatara, N. Stojaković, V. Vujić-Aleksić, B. Carić, D. Mandić, Klinička farmakologija u gerijatriji, Medicinski fakultet, Univerzitet u Banjoj Luci, 2018
Vascular effects of midazolam, flumazenil and a novel imidazobenzodiazepine MP-III-058 on isolated rat aorta. (2023-09)

M. Gajić Bojić, M. Treven, K. Pandey, V. Tiruveedhula, A. Santrač, Đ. Đukanović, N. Vojinović, LJ. Amidžić, R. Škrbić, P. Scholze, M. Ernst, J. Cook, M. Savić, Vascular effects of midazolam, flumazenil and a novel imidazobenzodiazepine MP-III-058 on isolated rat aorta., Sep, 2023
Kardioprotektivni efekti liraglutida u eksperimentalnom modelu izoprenalinske kardiotoksičnosti. (2023-09)

M. Stojiljković, R. Škrbić, Z. Bajić, T. Šobot, M. Gajić Bojić, Đ. Đukanović, S. Uletilović, N. Mandić-Kovačević, T. Cvjetković, A. Krivokuća, U. Maličević, D. Đurić, Kardioprotektivni efekti liraglutida u eksperimentalnom modelu izoprenalinske kardiotoksičnosti., Sep, 2023
Kardiometabolički efekti ekstrakta kore nara: rezultati kliničkih i eksperimentalnih studija. (2023-09)

R. Škrbić, M. Grabež, S. Marinković, Z. Bajić, T. Šobot, M. Gajić Bojić, Đ. Đukanović, M. Duran, S. Uletilović, N. Mandić-Kovačević, T. Cvjetković, A. Krivokuća, U. Maličević, M. Čolić, N. Miljuš, D. Đurić, M. Stojiljković, Kardiometabolički efekti ekstrakta kore nara: rezultati kliničkih i eksperimentalnih studija., Sep, 2023
Vascular effects of midazolam, flumazenil and a novel imidazobenzodiazepine MP-III-058 on isolated rat aorta. (2023-09)

M. Gajić Bojić, M. Treven, K. Pandey, V. Tiruveedhula, A. Santrač, Đ. Đukanović, N. Vojinović, LJ. Amidžić, R. Škrbić, P. Scholze, M. Ernst, J. Cook, M. Savić, Vascular effects of midazolam, flumazenil and a novel imidazobenzodiazepine MP-III-058 on isolated rat aorta., Sep, 2023
Liraglutide, a GLP-1 receptor agonist, attenuates isoprenaline-induced acute myocardila injury via inhibition of the Wnt/β-catenin signalling pathway. (2023-10)

R. Škrbić, Z. Bajić, LJ. Amidžić, N. Vojinović, M. Barudžija, T. Šobot, M. Gajić Bojić, T. Cvjetković, U. Maličević, A. Krivokuća, Đ. Đukanović, S. Uletilović, M. Stojiljković, Liraglutide, a GLP-1 receptor agonist, attenuates isoprenaline-induced acute myocardila injury via inhibition of the Wnt/β-catenin signalling pathway., Oct, 2023

Уноси

Dijagnostičko - terapijski vodić za porodičnu medicinu: Srčana insuficijencija (2007)

Effects of Semaglutide Treatment on Psoriatic Lesions in Obese Patients with Type 2 Diabetes Mellitus: An Open-Label, Randomized Clinical Trial (2025-01)

SIGNIFICANCE OF CYP2C9 IN PRESCRIBING SIPONIMOD THERAPY IN PATIENTS WITH MULTIPLE SCLEROSIS (2024-05)

Glutathione Transferase P1 Polymorphism rs1138272 Might be a Risk Determinant in Myocardial Infarction (2024-10)

Assessment of ADRB2 Genetic Polymorphisms with Risk for Myocardial Infarction in Patients from the Republic of Srpska (2024-10)

Peripheral GABAA receptors - physiological relevance and therapeutic implications (2024-11)

Modulation of Orosomucoid-like Protein 3 Activity in the Management of Inflammatory Bowel Disease (2024-10)

Characteristics and Outcomes of Critically Ill Pregnant/Postpartum Women with COVID-19 Pneumonia in Western Balkans, The Republic of Srpska Report (2022)

Do dynamic changes in haematological and biochemical parameters predict mortality in critically ill COVID-19 patients? (2024)

Dynamic changes in coagulation, hematological and biochemical parameters as predictors of mortality in critically ill COVID–19 patients: A prospective observational study. (2023-02)

Comparative Efficacy of High-Dose Dexamethasone Versus Methylprednisolone in Coronavirus Disease 2019 (COVID-19)-Associated Acute Respiratory Distress Syndrome (2024-03)

Medication Discrepancies in Patients After Transition of Care from Intensive Care Unit to Ward and At Hospital Discharge: A Pilot Study (2024-06)

Cardioprotective effects of liraglutide pretreatment on isoprenaline-induced myocardial injury in rats (2023)

Klinička farmakologija u gerijatriji (2018)

Vascular effects of midazolam, flumazenil and a novel imidazobenzodiazepine MP-III-058 on isolated rat aorta. (2023-09)

Kardioprotektivni efekti liraglutida u eksperimentalnom modelu izoprenalinske kardiotoksičnosti. (2023-09)

Kardiometabolički efekti ekstrakta kore nara: rezultati kliničkih i eksperimentalnih studija. (2023-09)

Vascular effects of midazolam, flumazenil and a novel imidazobenzodiazepine MP-III-058 on isolated rat aorta. (2023-09)

Liraglutide, a GLP-1 receptor agonist, attenuates isoprenaline-induced acute myocardila injury via inhibition of the Wnt/β-catenin signalling pathway. (2023-10)